Physician profile
Brian M Smith
NPI 1861658247
$29,065.73
in general payments reported to CMS, 2019-2025
18 companies · $25K in 2025
The $25K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,285 · 2020: $108 · 2021: $232 · 2022: $77.81 · 2023: $806 · 2024: $555 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Food and Beverage: $1,505 · Education: $750 · Travel and Lodging: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,500.00 |
| Food and Beverage | $1,505.31 |
| Education | $750.00 |
| Travel and Lodging | $607.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $24,573.40 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $2,866.56 | 2019-2024 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $417.73 | 2019-2025 | Biodrestore, Medihoney, Biofix |
| Distalmotion US | $366.30 | 2025 | Dexter L6 Robot |
| Stryker Corporation | $173.04 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Galderma Laboratories, L.P. | $149.97 | 2021 | |
| Davol INC. | $144.40 | 2020-2024 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $74.73 | 2019-2020 | |
| Ardelyx, INC. | $70.58 | 2024-2025 | Ibsrela |
| Biocomposites INC | $59.63 | 2019 | |
| Zimmer Biomet Holdings, INC. | $31.73 | 2024 | Rosa |
| Organogenesis INC. | $31.10 | 2024 | |
| Therapeuticsmd, INC. | $25.82 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.70 | 2025 | Entyvio |
| Ethicon US, LLC | $18.04 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $17.27 | 2019 | |
| Kci USA, INC. | $14.92 | 2019 | |
| Kerecis Limited | $10.81 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.